Northern Trust’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$58.9M Buy
1,363,683
+76,836
+6% +$3.32M 0.01% 995
2025
Q1
$44.5M Sell
1,286,847
-36,411
-3% -$1.26M 0.01% 1152
2024
Q4
$36.3M Buy
1,323,258
+43,955
+3% +$1.21M 0.01% 1320
2024
Q3
$32.6M Buy
1,279,303
+150,284
+13% +$3.83M 0.01% 1312
2024
Q2
$28.6M Sell
1,129,019
-190
-0% -$4.81K ﹤0.01% 1339
2024
Q1
$34.9M Sell
1,129,209
-25,763
-2% -$797K 0.01% 1236
2023
Q4
$46.6M Buy
1,154,972
+1,057
+0.1% +$42.7K 0.01% 1057
2023
Q3
$30.4M Buy
1,153,915
+24,643
+2% +$650K 0.01% 1268
2023
Q2
$19.4M Buy
1,129,272
+171,915
+18% +$2.96M ﹤0.01% 1601
2023
Q1
$15.9M Buy
957,357
+16,189
+2% +$268K ﹤0.01% 1706
2022
Q4
$7.17M Buy
941,168
+5,130
+0.5% +$39.1K ﹤0.01% 2235
2022
Q3
$9.31M Sell
936,038
-30,513
-3% -$303K ﹤0.01% 2026
2022
Q2
$8.78M Sell
966,551
-30,739
-3% -$279K ﹤0.01% 2124
2022
Q1
$10.1M Sell
997,290
-14,478
-1% -$147K ﹤0.01% 2141
2021
Q4
$16.9M Sell
1,011,768
-103,631
-9% -$1.73M ﹤0.01% 1897
2021
Q3
$52.3M Buy
1,115,399
+37,336
+3% +$1.75M 0.01% 1042
2021
Q2
$65.7M Buy
1,078,063
+49,053
+5% +$2.99M 0.01% 923
2021
Q1
$63.4M Buy
1,029,010
+196,174
+24% +$12.1M 0.01% 936
2020
Q4
$59.2M Sell
832,836
-19,704
-2% -$1.4M 0.01% 942
2020
Q3
$32M Buy
852,540
+62,103
+8% +$2.33M 0.01% 1249
2020
Q2
$25.8M Buy
790,437
+8,455
+1% +$276K 0.01% 1405
2020
Q1
$22.7M Buy
781,982
+474,058
+154% +$13.7M 0.01% 1309
2019
Q4
$10.8M Buy
307,924
+9,033
+3% +$317K ﹤0.01% 2126
2019
Q3
$6.42M Buy
+298,891
New +$6.42M ﹤0.01% 2404
2019
Q2
Hold
0
4272